Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie oncology pipeline continues to show progress
Medical Marketing and Media
Mon, 12/8/14 - 11:21 pm
AbbVie
oncology
Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
Seeking Alpha
Tue, 12/2/14 - 08:54 am
Sovaldi
AbbVie
Gilead Sciences
hepatitis C
AbbVie adds children's AIDS drugs to shared patent pool
Yahoo/Reuters
Mon, 12/1/14 - 07:56 am
AbbVie
AIDS
patents
AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia
Yahoo
Fri, 11/21/14 - 08:12 am
AbbVie
Singapore
drug manufacturing
Asia
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
Why are M&A hedge funds gun shy? Blame AbbVie for killing its Shire deal
Fierce Pharma
Fri, 11/14/14 - 09:53 am
M&A
AbbVie
Shire
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
hepatitis C
AbbVie
Achillion
Gilead Sciences
Merck
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tue, 11/11/14 - 09:55 am
AbbVie
hepatitis C
ombitasvir
ritonavir
dasabuvir
ABT-450
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Fri, 11/7/14 - 10:11 am
AbbVie
Gilead Sciences
Enanta
Harvoni
hepatitis C
Who Needs AbbVie? Goldman Adds Shire to Conviction List
WSJ Online
Wed, 11/5/14 - 07:32 pm
Shire
AbbVie
M&A
Investors Could Triple Their Investments in AbbVie
Yahoo/Guru Focus
Sat, 11/1/14 - 12:48 pm
AbbVie
AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal
WSJ Online
Fri, 10/31/14 - 02:02 pm
AbbVie
M&A
Rick Gonzalez
AbbVie Raises Earnings Guidance After Humira Sales Surge
Bloomberg
Fri, 10/31/14 - 08:23 am
AbbVie
earnings
Humira
AbbVie Expected To Post Mixed Q3 Results
Bidness Etc.
Wed, 10/29/14 - 10:16 am
AbbVie
earnings
U.S. law firm says investigating AbbVie over collapsed Shire deal
Yahoo/Reuters
Wed, 10/29/14 - 10:13 am
AbbVie
Shire
M&A
Shire’s Got Big Plans for AbbVie’s Breakup Fee
WSJ Online
Fri, 10/24/14 - 07:05 pm
AbbVie
Shire
M&A
Allergan
AbbVie finally admits it was trying to dodge U.S. taxes
Fortune
Wed, 10/22/14 - 06:57 pm
AbbVie
Shire
tax inversions
M&A
AbbVie's $55B deal for Shire is officially dead. Now what?
Fierce Biotech
Tue, 10/21/14 - 09:26 am
AbbVie
Shire
M&A
Pages
« first
‹ previous
…
61
62
63
64
65
66
67
68
69
…
next ›
last »